应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
OKUR OnKure Therapeutics, Inc.
未开盘 04-16 16:00:00 EDT
2.93
-0.07
-2.33%
盘后
2.93
+0.00
0.00%
16:05 EDT
最高
3.05
最低
2.82
成交量
1.52万
今开
3.05
昨收
3.00
日振幅
7.67%
总市值
3,937万
流通市值
1,247万
总股本
1,344万
成交额
4.47万
换手率
0.36%
流通股本
425.75万
市净率
0.38
ROE
-79.92%
每股收益
-15.28
52周最高
190.00
52周最低
2.57
市盈率
-0.19
股息
0.00
股息收益率
0.00
ROA
-44.43%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
奥本海默:维持OnKure Therapeutics(OKUR.US)评级,由优于大市调整至优于大市评级, 目标价由35.00美元调整至30.00美元。
金融界 · 03-11
奥本海默:维持OnKure Therapeutics(OKUR.US)评级,由优于大市调整至优于大市评级, 目标价由35.00美元调整至30.00美元。
OnKure Therapeutics(OKUR.US):2024年Q4财报实现营收0美元;每股收益为-1.37美元,前值为-30.14美元,预期值为-0.74美元。
金融界 · 03-10
OnKure Therapeutics(OKUR.US):2024年Q4财报实现营收0美元;每股收益为-1.37美元,前值为-30.14美元,预期值为-0.74美元。
OnKure Therapeutics 2024年第四季度GAAP每股收益$(1.37)未达到$(0.74)的预期
财报速递 · 03-10
OnKure Therapeutics 2024年第四季度GAAP每股收益$(1.37)未达到$(0.74)的预期
加载更多
公司概况
公司名称:
OnKure Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
2021-04-09
主营业务:
OnKure Therapeutics, Inc.于2014年9月22日在特拉华州注册成立。OnKure是一家临床阶段的生物制药公司,专注于发现和开发同类最佳的精准药物,这些药物针对可获得的疗法服务不足的癌症的生物验证驱动因素。使用基于结构的药物设计平台,OnKure正在构建一个强大的肿瘤不可知性候选药物管道,这些候选药物旨在实现最佳疗效和耐受性。OnKure正在开发OKI-219,一种选择性PI3K α H1047R抑制剂,作为其先导项目。OnKure的目标是成为靶向致癌PI3K α的领导者,并拥有多个旨在实现这一关键癌基因的同类最佳靶向的项目。
发行价格:
15.00
{"stockData":{"symbol":"OKUR","market":"US","secType":"STK","nameCN":"OnKure Therapeutics, Inc.","latestPrice":2.93,"timestamp":1744833600000,"preClose":3,"halted":0,"volume":15165,"hourTrading":{"tag":"盘后","latestPrice":2.93,"preClose":2.93,"latestTime":"16:05 EDT","volume":27,"amount":79.11,"timestamp":1744833904743},"delay":0,"floatShares":4257469,"shares":13435826,"eps":-15.280509,"marketStatus":"未开盘","change":-0.07,"latestTime":"04-16 16:00:00 EDT","open":3.05,"high":3.05,"low":2.82,"amount":44717.801332,"amplitude":0.076667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.280509,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744876800000},"marketStatusCode":0,"adr":0,"listingDate":1617940800000,"exchange":"NASDAQ","adjPreClose":3,"postHourTrading":{"tag":"盘后","latestPrice":2.93,"preClose":2.93,"latestTime":"16:05 EDT","volume":27,"amount":79.11,"timestamp":1744833904743},"volumeRatio":0.416241},"requestUrl":"/m/hq/s/OKUR","defaultTab":"news","newsList":[{"id":"2518746364","title":"奥本海默:维持OnKure Therapeutics(OKUR.US)评级,由优于大市调整至优于大市评级, 目标价由35.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518746364","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518746364?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:41","pubTimestamp":1741696890,"startTime":"0","endTime":"0","summary":"奥本海默:维持OnKure Therapeutics(OKUR.US)评级,由优于大市调整至优于大市评级, 目标价由35.00美元调整至30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11204148668013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","OKUR"],"gpt_icon":0},{"id":"2518789118","title":"OnKure Therapeutics(OKUR.US):2024年Q4财报实现营收0美元;每股收益为-1.37美元,前值为-30.14美元,预期值为-0.74美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789118","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518789118?lang=zh_cn&edition=full","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics(OKUR.US):2024年Q4财报实现营收0美元;每股收益为-1.37美元,前值为-30.14美元,预期值为-0.74美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OKUR","LENZ"],"gpt_icon":0},{"id":"1104892081","title":"OnKure Therapeutics 2024年第四季度GAAP每股收益$(1.37)未达到$(0.74)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1104892081","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104892081?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:14","pubTimestamp":1741637672,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics(LENZ) (NASDAQ:OKUR)报告的季度每股亏损为$(1.37),未达到分析师普遍预期的$(0.74),低于预期85.14%。以上内容来自Benzinga Earnings专栏,原文如下:OnKure $Therapeutics(LENZ)$ (NASDAQ:OKUR) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(0.74) by 85.14 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKUR","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onkuretherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0698},{"period":"1month","weight":-0.3921},{"period":"3month","weight":-0.5125},{"period":"6month","weight":-0.8417},{"period":"1year","weight":-0.8224},{"period":"ytd","weight":-0.6593}],"compareEarnings":[{"period":"1week","weight":-0.0419},{"period":"1month","weight":-0.0732},{"period":"3month","weight":-0.1115},{"period":"6month","weight":-0.1008},{"period":"1year","weight":0.0439},{"period":"ytd","weight":-0.1031}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"OnKure Therapeutics, Inc.于2014年9月22日在特拉华州注册成立。OnKure是一家临床阶段的生物制药公司,专注于发现和开发同类最佳的精准药物,这些药物针对可获得的疗法服务不足的癌症的生物验证驱动因素。使用基于结构的药物设计平台,OnKure正在构建一个强大的肿瘤不可知性候选药物管道,这些候选药物旨在实现最佳疗效和耐受性。OnKure正在开发OKI-219,一种选择性PI3K α H1047R抑制剂,作为其先导项目。OnKure的目标是成为靶向致癌PI3K α的领导者,并拥有多个旨在实现这一关键癌基因的同类最佳靶向的项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.092619},{"month":2,"riseRate":0.5,"avgChangeRate":-0.067893},{"month":3,"riseRate":0.5,"avgChangeRate":0.107812},{"month":4,"riseRate":0.5,"avgChangeRate":0.046391},{"month":5,"riseRate":0,"avgChangeRate":-0.158263},{"month":6,"riseRate":0.25,"avgChangeRate":-0.015452},{"month":7,"riseRate":0.5,"avgChangeRate":0.105182},{"month":8,"riseRate":0.25,"avgChangeRate":-0.003256},{"month":9,"riseRate":0.75,"avgChangeRate":0.03752},{"month":10,"riseRate":0.75,"avgChangeRate":0.005768},{"month":11,"riseRate":0.25,"avgChangeRate":-0.163217},{"month":12,"riseRate":0.5,"avgChangeRate":-0.225585}],"exchange":"NASDAQ","name":"OnKure Therapeutics, Inc.","nameEN":"OnKure Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"OnKure Therapeutics, Inc.(OKUR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供OnKure Therapeutics, Inc.(OKUR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"OnKure Therapeutics, Inc.,OKUR,OnKure Therapeutics, Inc.股票,OnKure Therapeutics, Inc.股票老虎,OnKure Therapeutics, Inc.股票老虎国际,OnKure Therapeutics, Inc.行情,OnKure Therapeutics, Inc.股票行情,OnKure Therapeutics, Inc.股价,OnKure Therapeutics, Inc.股市,OnKure Therapeutics, Inc.股票价格,OnKure Therapeutics, Inc.股票交易,OnKure Therapeutics, Inc.股票购买,OnKure Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"OnKure Therapeutics, Inc.(OKUR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供OnKure Therapeutics, Inc.(OKUR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}